Zur Kurzanzeige

dc.contributor.authorMoreno Ramos, Miriam
dc.contributor.authorSánchez Barba, Mercedes 
dc.contributor.authorGarcía Sánchez, Rubén
dc.contributor.authorMirón Canelo, José Antonio 
dc.contributor.authorGonzález Núñez, Verónica 
dc.date.accessioned2026-01-21T09:51:51Z
dc.date.available2026-01-21T09:51:51Z
dc.date.issued2021
dc.identifier.citationMoreno-Ramos, M., Sánchez-Barba, M., Sánchez, R. G., Mirón-Canelo, J. A., & González-Nuñez, V. (2022). Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain). Children, 9(1). https://doi.org/10.3390/CHILDREN9010025es_ES
dc.identifier.urihttp://hdl.handle.net/10366/169117
dc.description.abstract[EN]Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence.es_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectNeonatal Abstinence Syndrome (NAS)es_ES
dc.subjectSubstance use disorderes_ES
dc.subjectOpiateses_ES
dc.subjectCastilla y Leónes_ES
dc.subjectCorrelational researches_ES
dc.subjectBiplotes_ES
dc.subject.meshAlcohol Abstinence *
dc.subject.meshEpidemiology *
dc.subject.meshSubstance Withdrawal Syndrome *
dc.subject.meshNeonatal Abstinence Syndrome *
dc.titleIncidence of neonatal abstinence syndrome (NAS) in Castilla y Leon (Spain)es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.3390/CHILDREN9010025es_ES
dc.identifier.doi10.3390/CHILDREN9010025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.essn2227-9067
dc.journal.titleChildrenes_ES
dc.volume.number9es_ES
dc.issue.number1es_ES
dc.page.initial25es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decsepidemiología *
dc.subject.decsabstinencia de alcohol *
dc.subject.decssíndrome de abstinencia de sustancias *
dc.subject.decssíndrome de abstinencia neonatal *


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Solange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional